Biotech China 2014

Cell Biology: Food and Drug Administration

Total Score People Score Events Score
28 22 24
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Personalized Medicine in Clinical Trials: What You Need to Know Now Elizabeth Mansfield, U.S. Food and Drug Administration, Rockville, MD Elizabeth Mansfield
January 31, 2013 11th Cytokines and Inflammation Differential Responsiveness of Human Hepatocytes and Blood Leukocytes to Interferon-alpha and -lambda Raymond Donnelly
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Career-Development Lunch Sessions Albert B. Deisseroth
April 11, 2011 Personalized Medicine Partnerships Conference Companion Diagnostics | FDA's Current Thinking Elizabeth Mansfield
April 4, 2011 RNAi & Single Cell Biology-2011 Summit TBA Hao Zhu
August 25, 2010 Co-Development of Drugs and Diagnostics Evidence Based Evaluation of New Molecular Diagnostic Tests – Going for the Gold Steven Gutman
August 24, 2010 Enabling Point-of-Care Diagnostics - Moving Towards Rapid Diagnosis Regulation of Novel Molecular Diagnostic Devices for POC Testing Francisco Martinez-Murillo
May 4, 2010 Biomarker World Congress 2010 Biomarkers and the Development of Personalized Medicine: A Regulatory Perspective Francis Kalush
Role of Biomarkers in Drug Development: Application in Late Phase Clinical Trials Yaning Wang
September 24, 2009 Track 2: Implementing Personalized Medicine : Inaugural Targeted Therapy The Potential Impact of Recently Approved and Emerging Molecular Diagnostics in Drug-Diagnostics Co-Development Francis Kalush
August 11, 2009 Inaugural Molecular Diagnostics for Infectious Disease Ensuring the Safety and Validity of Molecular Diagnostic Tests Alberto Gutierrez
August 10, 2009 Second Annual Trends in Cancer Diagnostics Ensuring the Safety and Validity of Molecular Diagnostic Tests Alberto Gutierrez
August 5, 2009 Drug Safety Strategies to De-Risk Compounds Application of Omic Technologies to Identify Biomarkers of Toxicity Donna L. Mendrick
What Is Needed From Biomarkers for Preclinical and Clinical Testing? Wendy Sanhai
Applying "Omics' Technologies to Identify Toxicity Biomarkers Donna L. Mendrick
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety KEYNOTE PANEL DISCUSSION Wendy Sanhai
June 4, 2009 Structure-Based Drug Design Main Conference Norman Baylor
May 30, 2008 ASCO Annual'08 Meeting cancer genetics-- Integration of Molecular Testing into Clinical Decision Making Steven Gutman
clinical trials-- Beyond RECIST: Meaningful and Acceptable Endpoints in Phase II Trials Robert L. Justice
tumor biology-- Integration of Molecular Testing into Clinical Decision Making Steven Gutman
March 25, 2008 Molecular Diagnostics Regulation of Diagnostic Tests Steven Gutman
March 25, 2008 PATHWAY ANALYSIS Pathway Tools in the Interpretation of Genomic Data in VXDS Federico Goodsaid
March 25, 2008 R&D Risk Mitigation Regulation of Diagnostic Tests Steven Gutman
March 25, 2008 Preclinical Development SDAR: Spectrometric Data Activity Relationship Modeling Dan Buzatu
March 25, 2008 CYTOKINE-BASED THERAPEUTICS Cytokine Receptor Signaling in Hematopoietic Stem Cells andMyeloprolferative Diseases Weida Tong
December 4, 2007 7th World Drug Discovery & Development Summit 2007 FDA KEYNOTE ADDRESS: REGULATORY ASPECTS OF BIOMARKER DEVELOPMENT AND VALIDATION Dr. Courtney C. Harper
October 15, 2007 Thirs Annual Quantitative PCR, MicroArrays, And Biologican Validation: Capturing the Complete Biological Story (Oct 15-17) Acceptance Criteria for Gene Expression Data (14:00-15:30) Bharat Joshi
Acceptance Criteria for Gene Expression Data: Common Challenges and Considerations for Validation and Standardization of Gene Expression Data (14:35-15:05) Bharat Joshi
September 19, 2007 Baculovirus Technology (Sep 19-20) Baculovirus: The Big Picture (08:30-10:35) Philip Krause
Baculovirus - The Big Picture: KEYNOTE PRESENTATION - Regulatory Evaluation of Baculovirus-Produced Vaccines (08:40-09:20) Philip Krause
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Eight Annual Metabolic Biomarkers; METABOLITE BIOMARKERS OF TOXICITY (13:30-15:00) Laura K. Schnackenberg
Eight Annual Metabolic Biomarkers; METABOLITE BIOMARKERS OF TOXICITY: NMR Metabolomics: Characterization of Multi-Age Rodent Pediatric Models of Toxicity (14:00-14:30) Laura K. Schnackenberg
Third Annual Toxicity Biomarkers; METABOLITE BIOMARKERS OF TOXICITY (13:30-15:00) Laura K. Schnackenberg
Third Annual Toxicity Biomarkers; METABOLITE BIOMARKERS OF TOXICITY: Characterization of Multi-Age Rodent Pediatric Models of Toxicity (14:00-14:30) Laura K. Schnackenberg
Pre-Conference Workshops; Biomarker Assay Development and Validation: Part II FDA Perspective on Development and Qualification of Biomarkers (13:00-13:30) Reena Philip
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.